Literature DB >> 17653521

A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice.

Keiichi Hirose1, Akira Marui, Yoshio Arai, Takamasa Nomura, Kozo Kaneda, Yu Kimura, Tadashi Ikeda, Masatoshi Fujita, Masao Mitsuyama, Yasuhiko Tabata, Masashi Komeda.   

Abstract

Catheter-related infection is one of the most serious complications. Microbes migrate along the catheter (the foreign material) from the wound at the insertion-site, leading to catheter-related infection. Basic fibroblast growth factor (bFGF) is a potent mitogen that promotes the growth and regeneration of organs and tissues in vivo. Catheter-related bacterial invasion was simulated by the invasion of inoculated bacteria into a transplanted foreign material. Sterile Dacron sheets (foreign materials) were implanted on the subcutis of 96 male mice (C57BL/6) randomized into four groups (n = 24 per group). Group A: Dacron sheets only; Group B: Dacron sheets treated with a plain gelatin hydrogel sheet; Group C: Dacron sheets treated with free bFGF (50 microg); Group D: Dacron sheets treated with sustained-release bFGF (50 microg). On day 7, "detachment test" (to measure the force needed to pull out the Dacron sheet) and microscopic evaluations were performed, and the tissue immediately above the Dacron sheet was inoculated with methicillin-resistant Staphylococcus aureus (MRSA) 1 x 10(6) colony-forming units. The total energy needed for pulling out the implanted Dacron sheet in Group D was significantly higher than other three groups (P < 0.01). Group D had a large granulation tissue area containing a large amount of collagen tissue and vessels microscopically. Two days after the MRSA inoculation, the number of MRSA in the Dacron sheet of Group D was smallest. Pretreatment with sustained-release form of bFGF promoted tissue regeneration and reduced catheter-related bacterial invasion, indicating a useful adjuvant for reducing catheter-related infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653521     DOI: 10.1007/s00380-006-0967-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

Review 1.  Catheter-related bloodstream infections, part I: pathogenesis, diagnosis, and management.

Authors:  Gianluigi Ferretti; Mario Mandala; Serena Di Cosimo; Cecilia Moro; Giuseppe Curigliano; Sandro Barni
Journal:  Cancer Control       Date:  2002 Nov-Dec       Impact factor: 3.302

2.  S-phase cell detection with a monoclonal antibody.

Authors:  H G Miltenburger; G Sachse; M Schliermann
Journal:  Dev Biol Stand       Date:  1987

3.  Intramyocardial delivery of basic fibroblast growth factor-impregnated gelatin hydrogel microspheres enhances collateral circulation to infarcted canine myocardium.

Authors:  T Yamamoto; N Suto; T Okubo; A Mikuniya; H Hanada; S Yagihashi; M Fujita; K Okumura
Journal:  Jpn Circ J       Date:  2001-05

4.  The natural history of bacterial biofilm graft infection.

Authors:  T M Bergamini; R A Corpus; K R Brittian; J C Peyton; W G Cheadle
Journal:  J Surg Res       Date:  1994-05       Impact factor: 2.192

5.  Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites.

Authors:  Karin Olson; Robert P Rennie; John Hanson; Mary Ryan; Jean Gilpin; Maria Falsetti; Thea Heffner; Shirley Gaudet
Journal:  J Infus Nurs       Date:  2004 Jan-Feb

Review 6.  Catheter-related infections.

Authors:  Philippe Eggimann; Hugo Sax; Didier Pittet
Journal:  Microbes Infect       Date:  2004-09       Impact factor: 2.700

7.  Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation.

Authors:  Yutaka Sakakibara; Kazunobu Nishimura; Keiichi Tambara; Masaya Yamamoto; Fanglin Lu; Yasuhiko Tabata; Masashi Komeda
Journal:  J Thorac Cardiovasc Surg       Date:  2002-07       Impact factor: 5.209

8.  The use of basic fibroblast growth factor (bFGF) for enhancement of bone ingrowth into pyrolized bovine bone.

Authors:  H Schliephake; F W Neukam; A Löhr; D Hutmacher
Journal:  Int J Oral Maxillofac Surg       Date:  1995-04       Impact factor: 2.789

9.  LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection.

Authors:  Robert S Poston; Shahid Husain; Damian Sorce; Ellieen Stanford; Shimon Kusne; Margaret Wagener; Bartley P Griffith; Robert L Kormos
Journal:  J Heart Lung Transplant       Date:  2003-08       Impact factor: 10.247

Review 10.  Recent developments in the cell biology of basic fibroblast growth factor.

Authors:  D B Rifkin; D Moscatelli
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  4 in total

Review 1.  Infection, inflammation, and bone regeneration: a paradoxical relationship.

Authors:  M V Thomas; D A Puleo
Journal:  J Dent Res       Date:  2011-01-19       Impact factor: 6.116

2.  Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.

Authors:  Motoyuki Kumagai; Akira Marui; Yasuhiko Tabata; Takahide Takeda; Masaya Yamamoto; Atsushi Yonezawa; Shiro Tanaka; Shigeki Yanagi; Toshiko Ito-Ihara; Takafumi Ikeda; Toshinori Murayama; Satoshi Teramukai; Toshiya Katsura; Kazuo Matsubara; Koji Kawakami; Masayuki Yokode; Akira Shimizu; Ryuzo Sakata
Journal:  Heart Vessels       Date:  2015-04-11       Impact factor: 2.037

3.  Noninvasive optical imaging of staphylococcus aureus bacterial infection in living mice using a Bis-dipicolylamine-Zinc(II) affinity group conjugated to a near-infrared fluorophore.

Authors:  W Matthew Leevy; Seth T Gammon; James R Johnson; Andrew J Lampkins; Hua Jiang; Manuel Marquez; David Piwnica-Worms; Mark A Suckow; Bradley D Smith
Journal:  Bioconjug Chem       Date:  2008-02-09       Impact factor: 4.774

4.  Real-time detection of implant-associated neutrophil responses using a formyl peptide receptor-targeting NIR nanoprobe.

Authors:  Jun Zhou; Yi-Ting Tsai; Hong Weng; Ewin N Tang; Ashwin Nair; Digant P Davé; Liping Tang
Journal:  Int J Nanomedicine       Date:  2012-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.